Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloprost Add-on to Bosentan in IPAH (COMBI)
NCT00120380Phase 4Terminated
- Sponsor
- Hannover Medical School
- Start
- Sep 2004
- Primary completion
- May 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of iloprost in idiopathic pulmonary arterial hypertension (IPAH) (2 arms), sponsored by Hannover Medical School. Primary endpoint: 6-Minute Walk Distance at 12 weeks. Started Sep 2004; status: terminated.
02
Drugs
iloprost
03
Conditions
idiopathic pulmonary arterial hypertension (IPAH)
Beyond the preview
Go deeper on NCT00120380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00120380.